Johannes Jungverdorben, PhD, is a senior research scientist at Memorial Sloan Kettering Cancer Center and project manager for Team Studer. He studied human iPSC-derived neuronal models of neurodegenerative diseases (namely Machado-Joseph disease/Spinocerebellar ataxia type 3) and focuses on protein homeostasis in diverse neuronal subtypes to uncover the selective vulnerability of neuronal subtypes amongst neurological disorders including Parkinson’s disease to drive the development of patient-specific tailored therapies.
Project Manager
Johannes Jungverdorben, PhD
Memorial Sloan Kettering Cancer Center
Johannes Jungverdorben, PhD, is a senior research scientist at Memorial Sloan Kettering Cancer Center and project manager for Team Studer. He studied human iPSC-derived neuronal models of neurodegenerative diseases (namely Machado-Joseph disease/Spinocerebellar ataxia type 3) and focuses on protein homeostasis in diverse neuronal subtypes to uncover the selective vulnerability of neuronal subtypes amongst neurological disorders including Parkinson’s disease to drive the development of patient-specific tailored therapies.
